Genotype-phenotype correlation for histamine N-methyltransferase in a Chinese Han population

被引:13
作者
Chen, GL
Wang, W
Xu, ZH
Zhu, B
Wang, LS
Zhou, G
Wang, D
Zhou, HH [1 ]
机构
[1] Cent S Univ, Inst Clin Pharmacol, Pharmacogenet Res Inst, Changsha 410078, Hunan, Peoples R China
[2] Med Coll Ohio, HEB, Dept Pathol, Toledo, OH 43614 USA
[3] Johnson & Johnson Pharmacoceut Res & Dev LLC, Clin Drug Evaluat, Raritan, NJ 08869 USA
基金
中国国家自然科学基金;
关键词
histamine N-methyltransferase; genotype; phenotype; genetic polymorphism; Chinese;
D O I
10.1016/S0009-8981(03)00239-0
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Two potential single-nucleotide polymorphisms (SNP) (C314T and A595G) exist in the gene for human histamine N-methyltransferase (HNMT). Methods: A radiochemical microassay was used to measure the erythrocyte HNMT activities, whereas the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was employed to perform the genetic analysis in 247 unrelated Chinese Han subjects. Results: All subjects had detectable HNMT activity. The activity of HNMT was gender related (males>females, p<0.0001), with a 5.5-fold individual variation. The distribution of HNMT activity was compatible with a normal distribution. There were 28 heterozygotes for the variant T314 allele among the 247 subjects, whereas no A595G transition was observed. All heterozygotes for the T314 allele displayed an intermediate or low HNMT activity, with an average HNMT activity being 34.0% lower than those with wild-type genotype (623.1+/-136.0 vs. 944.8+/-249.3 U/ml red blood cells [RBC], p<0.0001). Conclusion: The C314T polymorphism was functionally important and contributes in part to phenotypic variance of HNMT activity in Chinese Han population. Additional unknown genetic or epigenetic factors should also play important roles in the regulation of HNMT activity. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:179 / 183
页数:5
相关论文
共 33 条
[1]   Human histamine N-methyltransferase gene: Structural characterization and chromosomal localization [J].
Aksoy, S ;
Raftogianis, R ;
Weinshilboum, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 219 (02) :548-554
[2]  
AZELROD J, 1971, J PHARMACOL EXP THER, V176, P650
[3]   HUMAN LIVER CATECHOL-O-METHYLTRANSFERASE PHARMACOGENETICS [J].
BOUDIKOVA, B ;
SZUMLANSKI, C ;
MAIDAK, B ;
WEINSHILBOUM, R .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (04) :381-389
[4]   HISTAMINE N-METHYLTRANSFERASE - INHIBITION BY MONOAMINE-OXIDASE INHIBITORS [J].
BOUDIKOVAGIRARD, B ;
SCOTT, MC ;
WEINSHILBOUM, R .
AGENTS AND ACTIONS, 1993, 40 (1-2) :1-10
[5]   Radio-enzymatic determination of histamine: Interference by fluoride and possible activation of histamine methyl transferase [J].
Bruce, C ;
Taylor, WH .
CLINICA CHIMICA ACTA, 1998, 276 (02) :157-162
[6]   Analysis of the C314T and A595G mutations in histamine N-methyltransferase gene in a Chinese population [J].
Chen, GL ;
Xu, ZH ;
Wang, W ;
Wang, GP ;
Zhou, G ;
Wang, D ;
Zhou, HH .
CLINICA CHIMICA ACTA, 2002, 326 (1-2) :163-167
[7]  
CHEN GL, 2003, IN PRESS PHARMACOGEN
[8]   Interindividual variability of histamine N-methyltransferase in the human liver and kidney [J].
De Santi, C ;
Donatelli, P ;
Giulianotti, PC ;
Pietrabissa, A ;
Mosca, F ;
Pacifici, GM .
XENOBIOTICA, 1998, 28 (06) :571-577
[9]   SIDECHAIN-MODIFIED HISTAMINE ANALOGS AS SUBSTRATES FOR HISTAMINE N-METHYLTRANSFERASE [J].
DENT, C ;
NILAM, F ;
SMITH, IR .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (13) :2297-2300
[10]  
FLODERUS Y, 1981, CLIN GENET, V19, P389